共 13 条
Genetic analysis of Brugada syndrome in Israel: Two novel mutations and possible genetic heterogeneity
被引:11
作者:
Levy-Nissenbaum, E
Eldar, M
Wang, Q
Lahat, H
Belhassen, B
Ries, L
Friedman, E
Pras, E
[1
]
机构:
[1] Tel Aviv Univ, Sheba Med Ctr, Sackler Sch Med, Inst Human Genet, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sheba Med Ctr, Sackler Sch Med, Henry Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sheba Med Ctr, Sackler Sch Med, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Israel
[4] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
[5] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Ctr Mol Genet, Cleveland, OH 44195 USA
[6] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Tel Aviv, Israel
[7] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源:
GENETIC TESTING
|
2001年
/
5卷
/
04期
关键词:
D O I:
10.1089/109065701753617480
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
Idiopathic ventricular fibrillation in patients with an electrocardiogram (ECG) pattern of right bundle branch block and ST-segment elevation in leads V1 to V3 (now frequently called Brugada syndrome) is associated with a high incidence of syncopal episodes or sudden death. The disease is inherited as an autosomal dominant trait. Mutations in SCN5A, a cardiac sodium channel gene, have been recently associated with Brugada syndrome. We have analyzed 7 patients from Israel affected with Brugada syndrome. The families of these patients are characterized by a small number of symptomatic members. Sequencing analysis of SCN5A revealed two novel mutations, G35S and R104Q, in two Brugada patients, and a possible R34C polymorphism in two unrelated controls. No mutations were detected in 5 other, patients, suggesting genetic heterogeneity. Low penetrance is probably the cause for the small number of symptomatic members in the two families positive for the SCN5A mutations.
引用
收藏
页码:331 / 334
页数:4
相关论文